Tomocube, Inc. (KOSDAQ:475960)

South Korea flag South Korea · Delayed Price · Currency is KRW
48,200
-1,650 (-3.31%)
At close: Sep 19, 2025
-3.31%
Market Cap638.86B
Revenue (ttm)6.81B
Net Income (ttm)-7.96B
Shares Out13.25M
EPS (ttm)-649.80
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume231,936
Average Volume310,341
Open48,950
Previous Close49,850
Day's Range47,450 - 50,900
52-Week Range9,930 - 51,900
Betan/a
RSI67.08
Earnings DateNov 14, 2025

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture
Founded 2015
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 475960
Full Company Profile

Financial Performance

In 2024, Tomocube's revenue was 5.94 billion, an increase of 58.48% compared to the previous year's 3.75 billion. Losses were -8.30 billion, -64.75% less than in 2023.

Financial Statements

News

There is no news available yet.